Stock·NYSE·Consumer Cyclical
Carvana Co. (CVNA)
- Market cap
- $65.65B
- P/E
- 31.34
- Dividend yield
- None
- Street target
- $83.00median of 24 analysts
- 52-week range
- $54.46 $97.38
CVNA stock forecast today
Where CVNA stands today, and what CleaRank Financial AI makes of it.
CVNA at a glance
Carvana Co. (CVNA): Hold, 51/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($66.02 and $69.59).
- Earnings CVNA beat estimates in 7 of its last 8 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $2.0B and bought $1.5M over the last 18 months.
- Valuation P/E of 31.3 against 20.8 for the Consumer Cyclical sector: a premium to peers (+51%).
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Carvana Co. (CVNA) Hold, with a model score of 51/100.
The analysts' outlook lifts the score most: 16 of 24 analysts rate it a buy and the median target is 40.1% above the price. The trend holds it back most: the price is 14.89% below its 200-day average and 10.28% below its 50-day average, and the 50-day average is 5.14% below the 200-day. The 50-day average stands at $66.02 and the 200-day at $69.59. Over the past year the price fell 16.61%.
Only on CleaRank
Figures we compute ourselves from CVNA's own price, earnings and insider-filing history. Tap one to see it in context.
CVNA stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $59.23 is 10.3% below the 50-day simple moving average of $66.02.Price above its 200-day average ›
The price is 14.9% below the 200-day simple moving average of $69.59.50-day average above the 200-day ›
The 50-day average ($66.02) is 5.1% below the 200-day average ($69.59), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 11% of its 52-week range, between $54.46 and $97.38.
CVNA share price
Pick a period: each tab shows how far CVNA has moved over it, to the last close.
Today's trading
Where CVNA sits inside today's range and its 52-week range.
CVNA fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 31.34 is 50.7% above the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 2.62 is 37.9% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $2.1B on revenue of $25.1B, a net margin of 8.5%.Beat estimates in most recent reports ›
CVNA beat the EPS estimate in 7 of its last 8 reports.
Key statistics
The headline figures for CVNA.
As of October 27, 2026, CVNA trades at $59.23, with a market value of $65.65B and a P/E ratio of 31.34.
What the numbers say
CleaRank Financial AI's reading of CVNA's valuation, growth and risks.
CVNA's trailing P/E is 31.34, against a Consumer Cyclical median of 20.8. That leaves it 50.7% above the sector median, and the peer comparison on this page rates the P/E as a premium to peers. Measured against sales, the price-to-sales ratio of 2.62 is 37.9% above the sector median of 1.9. To put the multiple in context, the company reported trailing earnings of $1.89 per share.
CVNA is growing faster than its sector. Revenue rose 52.40% in the latest quarter year on year, compared with a sector median of 7.2%. The company keeps 6.26% of sales as net profit and 9.22% as operating margin. Its return on equity of 58.77% is above the sector median of 12.4%, and debt-to-equity stands at 1.11.
CVNA beat the estimate by 10.53% in its latest quarterly report, released on July 29, 2026. Earnings per share came in at $0.42 against an expected $0.38. Even so, the share price dropped 7.36% in the following session.
CVNA has beaten the EPS estimate in 7 of its last 8 reports, yet a beat has not reliably meant a higher share price: the stock fell the next session after 4 of those beats. For this fiscal year, analysts expect EPS of $1.56, a drop of 7.5%. Next year they expect $2.26, a rise of 44.4%.
Daily swings are the main risk to plan for. On an average session CVNA moves 2.88%, and its beta against the S&P 500 is 3.55. A P/E of 31.34 sits 50.7% above the sector median, which the peer comparison reads as a premium to peers, so any shortfall in results would be judged against a high bar. The trend also works against holders until the price climbs back above its moving averages. For reference, the price is 39.18% below the 52-week high of $97.38.
CVNA against the Consumer Cyclical sector
How CVNA compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: CVNA trades at a significant premium to sector peers (+51%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 15, 2025, CVNA has lost 0.4% against a gain of 30.4% for SPY.
Performance against SPY
CVNA and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much CVNA sells, and how much of it becomes profit.
Revenue growth: Revenue grew 48.6% in FY2025 to $20.3B, from $13.7B a year earlier.
Profit margin: The net margin was 9.3% in FY2025, up from 3.0% the year before.
Profitable: CVNA earned $1.9B in FY2025.
Earnings reality check
Did CVNA beat what analysts expected, and how did the stock react?
Earnings record: CVNA beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 29, 2026after close | $0.38 | $0.42 | +10.53% | -7.36% | +4.76% |
| Apr 29, 2026after close | $0.30 | $0.34 | +13.33% | -0.20% | -1.82% |
| Feb 18, 2026after close | $0.24 | $0.84 | +250.00% | -7.95% | -7.37% |
| Oct 29, 2025after close | $0.26 | $0.21 | -19.23% | -13.81% | -12.51% |
| Jul 30, 2025after close | $0.21 | $0.26 | +23.81% | +16.96% | +6.39% |
| May 7, 2025after close | $0.15 | $0.30 | +100.00% | +10.17% | +17.88% |
| Feb 19, 2025after close | $0.05 | $0.12 | +140.00% | -12.10% | -17.45% |
| Oct 30, 2024after close | $0.04 | $0.13 | +225.00% | +19.29% | +15.25% |
As of October 27, 2026, CVNA has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on July 29, 2026, came in 10.53% above the estimate and the stock moved -7.36% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CVNA AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 43.5, in neutral territory.RSI above 50 ›
An RSI of 43.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CVNA
The score, the reasoning behind it, and what could move the price next.
Carvana Co. (CVNA) is trading in a downtrend. At $59.23, the stock sits 10.28% below its 50-day average of $66.02 and 14.89% below its 200-day average of $69.59. Its position in the 52-week range is near the bottom: the price is 8.75% above the low of $54.46, and 39.18% below the high of $97.38. Because the 50-day average is 5.14% below the 200-day average, the shorter-term trend is weaker than the longer one.
The recent returns are all negative: the price fell 10.35% over the past three months, fell 27.13% over the past six months and fell 16.61% over the past year. The 14-day RSI of 43.5 is in the neutral zone, and the MACD line is negative.
Rating reaffirmed ›
Wells Fargo kept its Overweight rating on October 23, 2026.
Source: Analyst action, Wells Fargo, October 23, 2026
Earnings beat, but the stock fell ›
The July 29, 2026 report beat the EPS estimate by 10.53%, and the share price fell 7.36% in the first session after it.
Source: Earnings report, July 29, 2026
- The two nearest levels to track are the 20-day EMA at $60.65, which sits above the price, and the 52-week low of $54.46, which sits below it.
- The 14-day RSI reads 43.5, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- Following the July 29, 2026 report, the share price fell 7.36% in the first session. Over the last 8 reports, CVNA has beaten estimates in 7 of them.
CVNA trades under its 50-day ($66.02) and 200-day ($69.59) averages, which is what makes the trend down; regaining the 50-day would be the first sign of repair. The nearest level above the price is the 20-day EMA at $60.65.
The next level below the price is the 52-week low of $54.46.
Technical indicators
Momentum and trend for CVNA, from its daily closes.
As of October 27, 2026, with CVNA at $59.23, its 14-day RSI is 43.5 (neutral territory), its 50-day simple moving average is $66.02 and its 200-day is $69.59.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CVNA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, CVNA's 1-year correlation of daily returns is +0.54 with S&P 500 (SPY), +0.51 with Nasdaq 100 (QQQ), +0.24 with Bitcoin (BTC) and +0.11 with gold (XAU).
CVNA price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
16 of 24 analysts rate it a buy or strong buy, 7 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $83.00 is 40.1% above the price.More buy ratings than three months ago ›
16 of 24 rate it a buy now, against 16 of 24 three months ago.
CVNA Wall Street View
12-month price targets
The price, $59.23, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 23, 2026 | Wells Fargo | Maintains | Overweight |
| Oct 15, 2026 | Morgan Stanley | Maintains | Overweight |
| Oct 9, 2026 | BTIG | Reiterates | Buy |
| Oct 6, 2026 | Stephens & Co. | Maintains | Overweight |
| Oct 6, 2026 | Barclays | Maintains | Overweight |
| Sep 30, 2026 | Oppenheimer | Maintains | Outperform |
As of October 27, 2026, 24 Wall Street analysts cover CVNA: 16 rate it a buy or strong buy, 7 a hold and 1 a sell or strong sell. Their 12-month price targets range from $60.00 to $120.00. The median CVNA price target is $83.00, 40.1% above the price of $59.23.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CVNA trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CVNA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CVNA's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CVNA tends to move, against the market and on its own.
CVNA price history and drawdowns
CVNA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 2.88% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 98.9%, from August 2021 to December 2022, regained by July 2025.Most 1-year holds ended higher ›
77% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in April 2017 is now worth $255,000, against $37,239 in the S&P 500 (SPY).
CVNA Drawdowns & Recovery
As of October 27, 2026, CVNA's worst peak-to-trough fall over the period since April 2017 with dividends reinvested was -98.9% (August 2021 to December 2022); it regained that peak by July 2025, 31 months after the low, and 77% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CVNA in April 2017 is worth now, against the same amount in the S&P 500.
Against the market: CVNA beat the S&P 500 over this period: $255,000 against $37,239.
A $10,000 investment in CVNA in April 2017 would be worth about $255,000 today with dividends reinvested, compared with about $37,239 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CVNA, and which have not.
Strongest month, June: an average of +32.50%, up in 8 of 10 years.
Weakest month, October: an average of -8.93%, up in 2 of 9 years.
This month, October: has averaged -8.93%, up in 2 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CVNA's strongest calendar month has been June (average +32.50%, up in 8 of 10 years) and its weakest October (average -8.93%, up in 2 of 9 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CVNA stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CVNA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 9 years of price history, projects that a $10,000 investment in CVNA today could grow to about $15,603 by 2030 in the base case, with a 90th-percentile outcome near $56,207 and a 10th-percentile outcome around $4,331. Projections are statistical simulations, not guarantees.
CVNA Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $92.41 for CVNA by 2030 in the base case, from $59.23 today (1.6x over 4 years). The 10th-percentile path ends near $25.65. These are outcomes of a Monte Carlo simulation run on CVNA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $34.88 | $66.20 | $126 | |
| 2028 | $29.89 | $73.98 | $183 | |
| 2029 | $27.25 | $82.69 | $251 | |
| 2030 | $25.65 | $92.41 | $333 |
Method: a lognormal simulation of CVNA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. CVNA is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
CVNA insider trading
What the people running the company have bought and sold.
CVNA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $1.5M on the open market and sold $2.0B.
As of October 27, 2026, CVNA insiders reported 246 open-market sales worth $2.0B and 1 open-market purchase worth $1.5M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Thomas Taira
Officer
|
Sell | 5.6K | $363.8K |
| Oct 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 63.8K | $3.9M |
| Oct 1, 2026 | Stephen R Palmer
Officer
|
Sell | 5.0K | $308.2K |
| Oct 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 63.8K | $223.6K |
| Sep 14, 2026 | Thomas Taira
Officer
|
Sell | 16.8K | $1.2M |
| Sep 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 63.8K | $4.6M |
| Sep 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 50.0K | $3.6M |
| Sep 1, 2026 | Stephen R Palmer
Officer
|
Sell | 5.0K | $357.8K |
| Sep 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 63.8K | $223.6K |
| Aug 14, 2026 | Ira J Platt
Director
|
Sell | 30.0K | $2.2M |
| Aug 14, 2026 | Dan Quayle
Director
|
Sell | 14.5K | $1.1M |
| Aug 14, 2026 | Ira J Platt
Director
|
Option | 30.0K | $90.0K |
| Aug 14, 2026 | Dan Quayle
Director
|
Option | 14.5K | $43.6K |
| Aug 3, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 63.8K | $4.1M |
| Aug 3, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 50.0K | $3.2M |
| Aug 3, 2026 | Stephen R Palmer
Officer
|
Sell | 5.0K | $322.5K |
| Aug 3, 2026 | Paul W Breaux
General Counsel
|
Grant | 85.3K | - |
| Aug 3, 2026 | Ernest C Garcia III
Chief Executive Officer
|
Grant | 134.7K | - |
| Aug 3, 2026 | Daniel J Gill
Officer
|
Grant | 119.9K | - |
| Aug 3, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Grant | 134.0K | - |
| Aug 3, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 63.8K | $223.6K |
| Aug 3, 2026 | Mark W Jenkins
Chief Financial Officer
|
Grant | 134.0K | - |
| Aug 3, 2026 | Ryan Scott Keeton
Officer
|
Grant | 56.7K | - |
| Aug 3, 2026 | Thomas Taira
Officer
|
Grant | 80.5K | - |
| Jul 31, 2026 | Michael E Maroone
Director
|
Buy | 25.0K | $1.5M |
| Jul 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 63.8K | $4.4M |
| Jul 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 50.0K | $3.4M |
| Jul 1, 2026 | Stephen R Palmer
Officer
|
Sell | 5.0K | $342.6K |
| Jul 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 63.8K | $223.6K |
| Jun 15, 2026 | Ira J Platt
Director
|
Sell | 15.0K | $1.0M |
| Jun 15, 2026 | Ira J Platt
Director
|
Option | 15.0K | $45.0K |
| Jun 10, 2026 | Dan Quayle
Director
|
Sell | 14.5K | $1.0M |
| Jun 10, 2026 | Dan Quayle
Director
|
Option | 14.5K | $43.6K |
| Jun 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 63.8K | $4.5M |
| Jun 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 50.0K | $3.5M |
| Jun 1, 2026 | Stephen R Palmer
Officer
|
Sell | 5.0K | $352.1K |
| Jun 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 50.0K | $100.5K |
| Jun 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 63.8K | $223.6K |
| May 8, 2026 | Thomas Taira
Officer
|
Sell | 5.6K | $2.2M |
| May 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $4.9M |
| May 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $3.8M |
| May 1, 2026 | Stephen R Palmer
Officer
|
Sell | 1.0K | $395.3K |
| May 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
| May 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 12.8K | $223.7K |
| Apr 29, 2026 | Paul W Breaux
General Counsel
|
Grant | 14.1K | - |
| Apr 29, 2026 | Ernest C Garcia III
Chief Executive Officer
|
Grant | 22.4K | - |
| Apr 29, 2026 | Daniel J Gill
Officer
|
Grant | 19.9K | - |
| Apr 29, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Grant | 22.2K | - |
| Apr 29, 2026 | Mark W Jenkins
Chief Financial Officer
|
Grant | 22.2K | - |
| Apr 29, 2026 | Ryan Scott Keeton
Officer
|
Grant | 10.3K | - |
| Apr 29, 2026 | Thomas Taira
Officer
|
Grant | 14.1K | - |
| Apr 14, 2026 | Michael E Maroone
Director
|
Grant | 1.2K | - |
| Apr 14, 2026 | Neha Parikh
Director
|
Grant | 1.1K | - |
| Apr 14, 2026 | Ira J Platt
Director
|
Grant | 1.2K | - |
| Apr 14, 2026 | Dan Quayle
Director
|
Grant | 1.1K | - |
| Apr 14, 2026 | Gregory B Sullivan
Director
|
Grant | 782 | - |
| Apr 8, 2026 | Thomas Taira
Officer
|
Sell | 3.8K | $1.3M |
| Apr 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $4.0M |
| Apr 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $3.1M |
| Apr 1, 2026 | Stephen R Palmer
Officer
|
Sell | 1.0K | $317.5K |
| Apr 1, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
| Apr 1, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 12.8K | $223.7K |
| Mar 12, 2026 | Ira J Platt
Director
|
Option | 10.0K | $150.0K |
| Mar 9, 2026 | Dan Quayle
Director
|
Sell | 2.9K | $898.9K |
| Mar 9, 2026 | Thomas Taira
Officer
|
Sell | 953 | $309.7K |
| Mar 9, 2026 | Dan Quayle
Director
|
Option | 2.9K | $43.5K |
| Mar 5, 2026 | Ira J Platt
Director
|
Grant | 7.8K | - |
| Mar 2, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $4.1M |
| Mar 2, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $3.2M |
| Mar 2, 2026 | Stephen R Palmer
Officer
|
Sell | 1.0K | $324.8K |
| Mar 2, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
| Mar 2, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 12.8K | $223.7K |
| Feb 9, 2026 | Thomas Taira
Officer
|
Sell | 1.0K | $417.3K |
| Feb 2, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $5.2M |
| Feb 2, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $4.1M |
| Feb 2, 2026 | Stephen R Palmer
Officer
|
Sell | 1.0K | $393.0K |
| Feb 2, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
| Feb 2, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 12.8K | $223.7K |
| Jan 8, 2026 | Thomas Taira
Officer
|
Sell | 1.2K | $524.8K |
| Jan 2, 2026 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $5.1M |
| Jan 2, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $4.0M |
| Jan 2, 2026 | Stephen R Palmer
Officer
|
Sell | 1.0K | $419.5K |
| Jan 2, 2026 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
| Jan 2, 2026 | Mark W Jenkins
Chief Financial Officer
|
Option | 12.8K | $223.7K |
| Dec 12, 2025 | Daniel J Gill
Officer
|
Sell | 40.0K | $19.0M |
| Dec 12, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 20.0K | $9.5M |
| Dec 12, 2025 | Paul W Breaux
General Counsel
|
Sell | 10.0K | $4.8M |
| Dec 12, 2025 | Paul W Breaux
General Counsel
|
Option | 10.0K | $100.7K |
| Dec 12, 2025 | Daniel J Gill
Officer
|
Option | 40.0K | $603.1K |
| Dec 12, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 20.0K | $201.4K |
| Dec 12, 2025 | Thomas Taira
Officer
|
Option | 10.0K | $100.7K |
| Dec 10, 2025 | Ira J Platt
Director
|
Grant | 2.0K | - |
| Dec 8, 2025 | Daniel J Gill
Officer
|
Sell | 80.0K | $35.2M |
| Dec 8, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 40.0K | $17.6M |
| Dec 8, 2025 | Thomas Taira
Officer
|
Sell | 31.0K | $13.5M |
| Dec 8, 2025 | Paul W Breaux
General Counsel
|
Sell | 20.0K | $8.8M |
| Dec 8, 2025 | Paul W Breaux
General Counsel
|
Option | 9.1K | $91.8K |
| Dec 8, 2025 | Daniel J Gill
Officer
|
Option | 80.0K | $4.5M |
| Dec 8, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 40.0K | $402.8K |
| Dec 8, 2025 | Thomas Taira
Officer
|
Option | 20.0K | $201.4K |
| Dec 3, 2025 | Michael E Maroone
Director
|
Sell | 30.9K | $12.4M |
| Dec 3, 2025 | Thomas Taira
Officer
|
Sell | 25.0K | $10.0M |
| Dec 3, 2025 | Ryan Scott Keeton
Officer
|
Sell | 10.0K | $4.0M |
| Dec 3, 2025 | Michael E Maroone
Director
|
Option | 30.9K | $463.9K |
| Dec 1, 2025 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $4.8M |
| Dec 1, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $3.8M |
| Dec 1, 2025 | Stephen R Palmer
Officer
|
Sell | 1.0K | $372.3K |
| Dec 1, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
| Dec 1, 2025 | Mark W Jenkins
Chief Financial Officer
|
Option | 12.8K | $223.7K |
| Nov 28, 2025 | Ryan Scott Keeton
Officer
|
Sell | 10.0K | $3.8M |
| Nov 28, 2025 | Thomas Taira
Officer
|
Sell | 10.0K | $3.8M |
| Nov 25, 2025 | Ryan Scott Keeton
Officer
|
Sell | 10.0K | $3.5M |
| Nov 12, 2025 | Gregory B Sullivan
Director
|
Sell | 2.5K | $850.0K |
| Nov 10, 2025 | Ryan Scott Keeton
Officer
|
Sell | 10.0K | $3.3M |
| Nov 10, 2025 | Thomas Taira
Officer
|
Sell | 952 | $309.4K |
| Nov 4, 2025 | Gregory B Sullivan
Director
|
Sell | 2.5K | $805.5K |
| Nov 3, 2025 | Mark W Jenkins
Chief Financial Officer
|
Sell | 12.8K | $4.1M |
| Nov 3, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Sell | 10.0K | $3.2M |
| Nov 3, 2025 | Stephen R Palmer
Officer
|
Sell | 1.0K | $305.0K |
| Nov 3, 2025 | Benjamin Edward Huston
Chief Operating Officer
|
Option | 10.0K | $100.7K |
Source: TwelveData, from SEC Form 4 filings
CVNA stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.